Despite receiving a long course of steroids, several courses of IVIG, and a few courses of Rituximab, her FVIII level remained critically low.<h4>Conclusion</h4>The rarity of AHA limits our understanding of this disease and the ability to perform trials to discover optimal therapies. This evidence concerns the gene F8 and autoimmune hemolytic anemia.